NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Carl Kirkpatrick
Monash University - Clayton / Australia
Others
AD Scientific Index ID: 119792
Monash University
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Carl Kirkpatrick's MOST POPULAR ARTICLES
1-)
Clinical pharmacokinetics of metforminGG Graham, J Punt, M Arora, RO Day, MP Doogue, J Duong, TJ Furlong, ...Clinical pharmacokinetics 50 (2), 81-98, 201111752011
2-)
Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—a meta-analysisJF Roos, J Doust, SE Tett, CMJ KirkpatrickClinical biochemistry 40 (5-6), 383-391, 20075682007
3-)
Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic reviewN Jokanovic, ECK Tan, MJ Dooley, CM Kirkpatrick, JS BellJournal of the American Medical Directors Association 16 (6), 535. e1-535. e12, 20153572015
4-)
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and …JA Roberts, CMJ Kirkpatrick, MS Roberts, TA Robertson, AJ Dalley, ...Journal of antimicrobial chemotherapy 64 (1), 142-150, 20094102009
5-)
Resveratrol does not benefit patients with nonalcoholic fatty liver diseaseVS Chachay, GA Macdonald, JH Martin, JP Whitehead, ...Clinical Gastroenterology and Hepatology 12 (12), 2092-2103. e6, 20143192014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept